Skip to main content

Table 2 The associations of ALDH1 expression levels in ovarian carcinoma cells and the clinical and pathologic characteristics

From: The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study

Ā 

ALDH1 IHC score in tumor cells

p-value

1 (negative)

2 (low)

3 (high)

Ā 

ā€ƒā€‰Number

Total N

98

111

39

Ā 

Age (years old):

Ā Ā Ā Ā Ā 

ā€ƒā€‰ā‰¤39

16

5 (31.3Ā %)

6 (37.5Ā %)

5 (31.3Ā %)

Ā 

ā€ƒā€‰40ā€“49

41

20 (48.8Ā %)

15 (36.6Ā %)

6 (14.6Ā %)

0.940

ā€ƒā€‰50ā€“59

64

20 (31.3Ā %)

34 (53.1Ā %)

10 (15.6Ā %)

Ā 

ā€ƒā€‰60ā€“69

72

28 (38.9Ā %)

35 (48.6Ā %)

9 (12.5Ā %)

Ā 

ā€ƒā€‰ā‰„70

39

13 (33.3Ā %)

18 (46.2Ā %)

8 (20.5Ā %)

Ā 

ā€ƒā€‰missing

16

Ā Ā Ā Ā 

Histological subtype:

Ā Ā Ā Ā Ā 

ā€ƒā€‰Serous carcinoma

163

67 (41.1Ā %)

80 (49.1Ā %)

16 (9.8Ā %)

Ā 

ā€ƒā€‰Mucinous carcinoma

18

4 (22.2Ā %)

3 (16.7Ā %)

11 (61.1Ā %)

<0.001

ā€ƒā€‰Endometrioid carcinoma

19

4 (21.1Ā %)

9 (47.4Ā %)

6 (31.6Ā %)

Ā 

ā€ƒā€‰Clear cell carcinoma

11

6 (54.5Ā %)

4 (36.4Ā %)

1 (9.1Ā %)

Ā 

ā€ƒā€‰Mixed epithelial tumor

11

2 (18.2Ā %)

6 (54.5Ā %)

3 (27.3Ā %)

Ā 

ā€ƒā€‰Undifferentiated tumor

5

3 (60.0Ā %)

1 (20.0Ā %)

1 (20.0Ā %)

Ā 

ā€ƒā€‰Unclassified tumor and others

21

Ā Ā Ā Ā 

FIGO Stage:

Ā Ā Ā Ā Ā 

ā€ƒā€‰I

28

7 (25.0Ā %)

11 (39.3Ā %)

10 (35.7Ā %)

Ā 

ā€ƒā€‰II

18

8 (44.4Ā %)

6 (33.3Ā %)

4 (22.2Ā %)

Ā 

ā€ƒā€‰III

117

47 (40.2Ā %)

55 (47.0Ā %)

15 (12.8Ā %)

0.032

ā€ƒā€‰IV

79

31 (38.2Ā %)

38 (48.1Ā %)

10 (12.7Ā %)

Ā 

Not staged or missing

6

Ā Ā Ā Ā 

Histological Grade:

Ā Ā Ā Ā Ā 

ā€ƒā€‰Well

19

4 (21.1Ā %)

9 (47.4Ā %)

6 (31.6Ā %)

Ā 

ā€ƒā€‰Moderate

62

20 (32.3Ā %)

35 (56.5Ā %)

7 (11.3Ā %)

0.012

ā€ƒā€‰Poor

133

58 (43.6Ā %)

60 (45.1Ā %)

15 (11.3Ā %)

Ā 

ā€ƒā€‰Not graded or missing

34

Ā Ā Ā Ā